nootkatone has been researched along with rotenone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, L; Guo, J; Li, J; Li, Q; Shi, J; Wan, G; Wang, X; Wang, Y; Wei, X; Yang, X; Yao, Z | 1 |
1 other study(ies) available for nootkatone and rotenone
| Article | Year |
|---|---|
Nootkatone alleviates rotenone-induced Parkinson's disease symptoms through activation of the PI3K/Akt signaling pathway.
Topics: Animals; Dopaminergic Neurons; Molecular Docking Simulation; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rotenone; Signal Transduction | 2022 |